INJECTIVE - The Stochastic Cross | INJ Price Prediction
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 24 Oct 2026, 01:39 UTC
- Recorded by Tahlil Plus
- 24 Oct 2026, 06:20 UTC
AI-generated source summary
The analysis focuses on the total crypto market cap excluding Bitcoin and stablecoins, as well as Bitcoin dominance and total crypto market cap. The presenter suggests that historical patterns in Bitcoin dominance, specifically during the 2017, 2021, and projected 2025 cycles, indicate a recurring pattern of dominance falling after reaching a peak, leading to altcoin seasons. Currently, Bitcoin dominance is at approximately 45%, and the presenter anticipates a further decline towards 3.5% in the long term, which historically correlates with a bullish period for altcoins. The analysis on the total crypto market cap excluding Bitcoin and stablecoins shows a pattern of massive pumps following consolidation phases. The presenter expects a similar upward movement in the total crypto market cap, potentially targeting levels above $1.2T, following a recent pullback. For Injective Protocol (INJ), the presenter highlights a consolidation pattern on the weekly chart, suggesting a potential for a significant upward move to a target of $35, with a fail bound at $5, indicating a bullish outlook.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.